KEGG   DRUG: Linagliptin
Entry
D09566                      Drug                                   
Name
Linagliptin (JAN/USAN/INN);
Tradjenta (TN)
Product
TRADJENTA (A-S Medication Solutions), TRADJENTA (Boehringer Ingelheim Pharmaceuticals), TRADJENTA (Cardinal Health 107)
Formula
C25H28N8O2
Exact mass
472.2335
Mol weight
472.5422
Structure
Class
Antidiabetic agent
 DG02044  Hypoglycemic agent
  DG01601  DPP-4 inhibitor
Remark
Therapeutic category: 3969
ATC code: A10BH05
Chemical structure group: DG03274
Product (DG03274): D09566<JP/US>
Product (mixture): D10264<US> D10588<JP/US> D11856<US>
Efficacy
Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor
  Disease
Type 2 diabetes mellitus [DS:H00409]
Comment
Treatment of type 2 diabetes
Target
DPP4 (CD26) [HSA:1803] [KO:K01278]
  Pathway
hsa04974  Protein digestion and absorption
Interaction
Structure map
map07051  Antidiabetics
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A10 DRUGS USED IN DIABETES
   A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
    A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
     A10BH05 Linagliptin
      D09566  Linagliptin (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
 Blood Glucose Regulators
  Antidiabetic Agents
   Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
    Linagliptin
     D09566  Linagliptin (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   396  Antidiabetic agents
    3969  Others
     D09566  Linagliptin (JAN/USAN/INN)
Drug groups [BR:br08330]
 Antidiabetic agent
  DG02044  Hypoglycemic agent
   DG01601  DPP-4 inhibitor
    DG03274  Linagliptin
     D09566  Linagliptin
Drug classes [BR:br08332]
 Antidiabetic agent
  DG01601  DPP-4 inhibitor
   D09566  Linagliptin
  DG02044  Hypoglycemic agent
   D09566  Linagliptin
Target-based classification of drugs [BR:br08310]
 Enzymes
  Hydrolases (EC3)
   Peptidyl-peptidases
    DPP4 (CD26)
     D09566  Linagliptin (JAN/USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D09566
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D09566
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D09566
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D09566
Drug groups [BR:br08330]
 Antidiabetic agent
  DG02044  Hypoglycemic agent
   DG01601  DPP-4 inhibitor
    DG03274  Linagliptin
Other DBs
CAS: 668270-12-0
PubChem: 124490306
ChEBI: 68610
PDB-CCD: 356[PDBj]
LigandBox: D09566
KCF data

ATOM        35
            1   C8x C    15.6073  -25.1957
            2   C8x C    15.6073  -26.5954
            3   C8x C    16.7971  -27.2953
            4   C8y C    18.1269  -26.5954
            5   C8y C    18.1269  -25.1957
            6   C8x C    16.7971  -24.4958
            7   C8y C    19.3167  -27.2953
            8   N5x N    20.5065  -26.5954
            9   C8y C    20.5065  -25.1957
            10  N5x N    19.3167  -24.4958
            11  C1a C    19.3167  -28.6950
            12  C1b C    21.6963  -24.4958
            13  N4y N    22.8860  -25.1957
            14  C8y C    22.8860  -26.5954
            15  N4y N    24.1458  -27.2953
            16  C8y C    25.3356  -26.5954
            17  C8y C    25.3356  -25.1957
            18  C8y C    24.1458  -24.4958
            19  O5x O    24.1458  -23.0960
            20  O5x O    21.6963  -27.2953
            21  C1a C    24.1458  -28.6950
            22  N5x N    26.6654  -27.0153
            23  C8y C    27.5053  -25.8955
            24  N4y N    26.6654  -24.7757
            25  N1y N    28.9050  -25.8955
            26  C1x C    29.6049  -27.0853
            27  C1y C    31.0046  -27.0853
            28  C1x C    31.7045  -25.8955
            29  C1x C    31.0046  -24.7057
            30  C1x C    29.6049  -24.7057
            31  N1a N    31.7045  -28.3451
            32  C1b C    27.3653  -23.5859
            33  C3b C    28.7650  -23.5859
            34  C3b C    30.1648  -23.5859
            35  C1a C    31.5646  -23.5859
BOND        39
            1     1   2 1
            2     2   3 2
            3     3   4 1
            4     4   5 2
            5     5   6 1
            6     1   6 2
            7     4   7 1
            8     7   8 2
            9     8   9 1
            10    9  10 2
            11    5  10 1
            12    7  11 1
            13    9  12 1
            14   12  13 1
            15   13  14 1
            16   14  15 1
            17   15  16 1
            18   16  17 2
            19   17  18 1
            20   13  18 1
            21   18  19 2
            22   14  20 2
            23   15  21 1
            24   16  22 1
            25   22  23 2
            26   23  24 1
            27   17  24 1
            28   23  25 1
            29   25  26 1
            30   26  27 1
            31   27  28 1
            32   28  29 1
            33   29  30 1
            34   25  30 1
            35   27  31 1 #Up
            36   32  33 1
            37   32  24 1
            38   33  34 3
            39   34  35 1

» Japanese version   » Back

  All links  
Ontology (10)   
   KEGG BRITE (10)   
Pathway (1)   
   KEGG PATHWAY (1)   
Disease (1)   
   KEGG DISEASE (1)   
Drug (2)   
   KEGG DGROUP (1)   
   LigandBox (1)   
Chemical substance (3)   
   PubChem (1)   
   ChEBI (1)   
   PDB-CCD (1)   
Gene (2)   
   KEGG ORTHOLOGY (1)   
   KEGG GENES (1)   
All databases (19)   

Download RDF
DBGET integrated database retrieval system